BridgeMD
New treatment option for IBD (Inflammatory Bowel Disease)
Official title MICI-BIO: Study on Patient With Chronic Inflammatory Bowel Disease
ClinicalTrials.gov ID: NCT07470502
What this study is testing
- What it's testing
- This is a monocentric, non-profit prospective cohort study with longitudinal biological sampling. The study will include patients with IBD starting biological therapy with infliximab.
- Time commitment: about 14 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 18
You may be able to join if
- Age between 3 and 18 years
- diagnosis of Crohn's disease or ulcerative colitis
- starting biological therapy with infliximab;
- Signed informed consent.
You likely can't join if
- Patients in whom the diagnosis of IBD has not been confirmed according to standardized endoscopic and histological criteria;
- Patients who refuse to participate in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Florence, Italy, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 14 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Florence, Italy, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.